Benefit evaluation in vitiligo treatment: Development and validation of a patient-defined outcome questionnaire

Dermatology

Volumn 217, Issue 2, 2008, Pages 101-106

  Augustin, M ^a   Gajur, A I ^a   Reich, C ^a   Rustenbach, S J ^a   Schaefer, I ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Individualized weighted outcome assessment; Patient benefit index; Quality of life; Vitiligo, patient reported outcomes

Indexed keywords

ARTICLE; CALCULATION; CRONBACH ALPHA COEFFICIENT; DISCRIMINANT VALIDITY; DRUG EFFECT; DRUG EFFICACY; EVALUATION; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PARAMETER; PATIENT BENEFIT INDEX; PATIENT NEED QUESTIONNAIRE; PATIENT SATISFACTION; PRIORITY JOURNAL; PUVA; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; VALIDATION PROCESS; VITILIGO;

EVALUATION STUDIES AS TOPIC; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; PATIENT PARTICIPATION; PSYCHOMETRICS; PUVA THERAPY; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; VITILIGO;

EID: 49649092007     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000128992     Document Type: Article

References (34)

1. Hahn SK, Nordlund JJ: Vitiligo. Oxford, Blackwell Sciences, 2000.
2. Arrunategui A, Arroyo C, Garcia L, Covelli L, Escobar C, Carrascal C, Falabella R: Melanocyte reservoir in vitiligo. Int J Dermatol 1994;33:484-487.
3. Salzer BA, Schallreuter KU: Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology 1995;190:109-115.
4. Schallreuter KU: Verdammte weisse Flecken. Bradford, University of Bradford, 1995.
5. Mechri A, Amri M, Douarika AA, Ali Hichem BH, Zouari B, Zili J: Psychiatric morbidity and quality of life in vitiligo: a case controlled study. Tunis Med 2006;84:632-635.
6. Ongenae K, Dierckxsens L, Brochez L, van Geel N, Naeyaert JM: Quality of life and stigmatisation profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology 2005;210:279-285.
7. Ongenae K, Van Geel N, De Schepper S, Naeyaert JM: Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol 2005;152:1165-1172.
8. Belhadjali H, Amri M, Mechri A, Doarika A, Khorchani H, Youssef M, Gaha L, Zili J: Vitiligo and quality of life: a case control study. Ann Dermatol Vénéréol 2007;134:233-236.
9. Borimnejad L, Parsa Yekta Z, Nikbakht-Nasrabadi A, Firooz A: Quality of life with vitiligo: comparison of male and female muslim patients in Iran. Gend Med 2006;3:124-130.
10. Fitzpatrick T, Eisen A, Wolff K, Freedberg I, Austen K (eds): Dermatology in General Medicine, ed 4, revised. New York, McGraw-Hill, 1993.
11. Van Geel N, Ongenae K, Haeghen YV, Vervaet C, Naeyert JM: Subjective and objective evaluation of noncultured epidermal cellular grafting for repigmenting vitiligi. Dermatology 2006;213:23-29.
12. Rychlik R, Rusche H, Augustin M: Systematik der Nutzenbewertung von Arzneimitteln. Gesundh Ökon Qual Manag 2004;9:245-252.
13. Zentner A, Velasco-Garrido M, Busse R: Methods for the comparative evaluation of pharmaceuticals. GMS Health Technol Assess 2005, vol 1, doc 09. http://www.egms.de/en/journals/hta/2005-1/hta000009.shtml (accessed May 29, 2007).
14. Bundesministerium für Gesundheit: Gesetz zur Stärkung des Wettbewerbs in der gesetzlichen Krankenversicherung vom 26.03.2007. Bundesanzeiger 2007;66:3613.
15. Fünftes Buch Sozialgesetzbuch (SGB V), § 35b Abs 1.
16. Bastian H, Bender R, Ernst AS, Kaiser T, Kirchner H, Kolominsky-Rabas P, Lange S, Sawicky PT, Weber M: Methoden. Version 2.0 vom 19.12.2006. Köln, Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, 2007.
17. Gemeinsamer Bundesausschuss: Verfahrensordnung vom 20.09.2005. Bundesanzeiger 2005;242:16998.
18. Zschocke I, Hammelmann U, Augustin M: Therapeutischer Nutzen in der dermatologischen Behandlung. Hautarzt 2005;56:839-846.
19. Bowling A: Measuring disease: a review of disease-specific quality of life measurement scales. Buckingham, Open University Press, 1995.
20. Brock D: Quality of life measures in health care and medical ethics; in Spilker B (ed): Quality of Life and Pharmacoeconomics in Clinical Trials, ed 2, revised. Philadelphia, Lippincott-Raven, 1996, pp 487-510.
21. Guyatt GH, Walter S, Norman G: Measuring change over time: assessing the usefulness of evaluative instruments. J Chron Dis 1987;40:171-178.
22. Lienert G: Testaufbau und Testanalyse, ed 5. Weinheim, Beltz, 1994.
23. Smith GT (ed): Measuring Health: A Practical Approach. Chichester, Wiley, 1988.
24. Clark MS, Caudrey DJ: Evaluation of rehabilitation services: the use of goal attainment scaling. Int Rehabil Med 1982;5:41-45.
25. Ottenbacher KJ, Cusick A: Goal attainment scaling as a method of clinical service evaluation. Am J Occup Ther 1990;44:519-525.
26. Fisher K, Hardie RJ: Goal attainment scaling in evaluating a multidisciplinary pain management programme. Clin Rehabil 2002;16:871-877.
27. Rushton PW, Miller WC: Goal attainment scaling in the rehabilitation of patients with lower-extremity amputations: a pilot study. Arch Phys Med Rehabil 2002;83:771-775.
28. Rockwood K, Howlett S, Stadnyk K, Carver D, Powell C, Stolee P: Responsiveness of goal attainment scaling in randomized controlled trial of comprehensive geriatric assessment. J Clin Epidemiol 2003;56:736-743.
29. Steinbook RM, Jacobson AF, Mosher JC, Davies DL: The goal attainment scale: an instructional guide for the delivery of social reinforcement. Arch Gen Psychiatry 1977;34:923-926.
30. Steffanowski A, Lichtenberg S, Schmidt J, Huber C, Wittmann WW, Nübling R: Ergebnisqualität psychosomatischer Rehabilitation: Zielerreichungsskalierung auf der Basis einer strukturierten Therapiezielliste. Rehabilitation 2004;43:219-232.
31. Zwingmann C: Zielorientierte Ergebnismessung (ZOE) mit dem IRES-Patientenfragebogen: Eine kritische Zwischenbilanz. Rehabilitation 2003;42:226-235.
32. Augustin M, Amon U, Braathen L, Bullinger M, Gieler U, Klein GF, Schultz-Amling W: Erfassung von Lebensqualität in der Dermatologie (Leitlinie). JDDG 2004;9:802-806.
33. The EuroQol group: EuroQol - a new facility for the measurement of health related quality of life. Health Policy 1990;16:199-208.
34. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-216.